UI Healthcare LogoInternal Medicine Home Pagespacer imageEducation InformationPatient Care InformationResearch Informationspacer imageDivisions of the DepartmentFaculty
Diversity and Culture ConferencesNews and EventsGiving Opportunitiesspacer imageServicesIntranet (login required)Useful LinksContact Usspacer imageThe University of Iowa

 

UI Healthcare Navigation Bar UI Healthcare Home Page About Us Appointments Contact UI Healthcare Staff Departments Health Topics Search

Department of Internal Medicine

Rheumatology Faculty


Gail Bishop, Ph.D.
Holden Chair in Cancer Biology
Professor of Microbiology & Internal Medicine
Assoc. Director for Basic Science Research, Holden Comprehensive Cancer Center
Director, Graduate Program in Immunology

Dr. Bishop's research investigates molecular mechanisms of lymphocyte activation and tolerance, in normal and malignant B cells.

Honors, Awards, and Organizations

  • American Association of Immunologists
  • American Society for Microbiology
  • American Society for Biochemistry & Molecular Biology
  • University of Michigan Rackham Fellowship, 1982-1983
  • Damon Runyon Cancer Fund Fellow, 1984-1986
  • National Arthritis Investigator Award, 1987-1990
  • Carver Foundation Faculty Fellow, 1994-1997
  • College of Medicine Endowed Chair in Medicine & Microbiology, 2001
  • Donald Dorfman Lymphoma Research Award, 2003
  • Graduate College Outstanding Mentor Award, 2003

  Gail Bishop photo

Graduate School:
Cellular and Molecular Biology, University of Michigan

Fellowship:
University of North Carolina

Recent Publications

  1. Hostager, B.S., Haxhinasto, S.A., Rowland, S. and Bishop, G.A.  TRAF2-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling.  J. Biol. Chem.278:45382-45390, 2003.
  2. Haxhinasto, S.A. and Bishop, G.A. Synergistic B cell activation by CD40 and the B cell antigen receptor: Role of BCR-mediated kinase activation and TRAF regulation. J. Biol. Chem.279:2575-2582, 2004.
  3. Xie, P., Hostager, B.S. and Bishop, G.A. Requirement for TRAF3 in signaling by the EBV-encoded oncoprotein LMP1, but not CD40, in B lymphocytes.  J. Exp. Med. 199:661-671, 2004.
  4. Stunz, L.L., Busch, L.K., Munroe, M.E., Sigmund, C.D., Tygrett, L.T., Waldschmidt, T.J., and Bishop, G.A.  Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture.  Immunity 21:255-266, 2004.
  5. Click here for additional publications.

Links of Interest

Back to Rheumatology Faculty List


UI Healthcare Home | About Us | Appointments | Contact UI Healthcare | Departments | Health Library | Search

Home | Education | Patient Care | Research
Divisions | Faculty | Conferences | News & Events | Giving Opportunities
Services | Intranet | Useful Links | Contact Us